Tyler Bussian
Stock Analyst at Brookline Capital
(0.17)
# 4,284
Out of 4,944 analysts
5
Total ratings
25%
Success rate
-23.23%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Tyler Bussian
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| COCH Envoy Medical | Initiates: Buy | $9 | $1.51 | +496.03% | 1 | Oct 14, 2024 | |
| CRVO CervoMed | Initiates: Buy | $63 | $9.64 | +553.53% | 1 | Jul 8, 2024 | |
| IMUX Immunic | Initiates: Buy | $10 | $0.83 | +1,105.84% | 1 | Apr 5, 2024 | |
| ANVS Annovis Bio | Downgrades: Hold | $9 | $2.70 | +233.33% | 2 | Feb 28, 2024 |
Envoy Medical
Oct 14, 2024
Initiates: Buy
Price Target: $9
Current: $1.51
Upside: +496.03%
CervoMed
Jul 8, 2024
Initiates: Buy
Price Target: $63
Current: $9.64
Upside: +553.53%
Immunic
Apr 5, 2024
Initiates: Buy
Price Target: $10
Current: $0.83
Upside: +1,105.84%
Annovis Bio
Feb 28, 2024
Downgrades: Hold
Price Target: $9
Current: $2.70
Upside: +233.33%